Nov 8 (Reuters) - Promis Neurosciences Inc PMN.TO
* Promis neurosciences initiates cohort study to evaluate prevalence of different amyloid beta prion strains in alzheimer's disease
* Promis neurosciences inc - first results of cohort study are anticipated in q1 2017. Source text for Eikon: ID:nCNW73MPKa Further company coverage: PMN.TO